GlobeX Data CEO Interviewed on Proactive to Announce it Sekur.com Has Been Selected by Stem Cell Company Hemostemix
GlobeX Data Ltd. (OTCQB:SWISF) has announced that its secure communications solution, Sekur, has been selected by Hemostemix Inc., a stem cell company listed on the TSX Ventures exchange. CEO Alain Ghiai noted that Hemostemix requires a private communications platform for regulatory interactions, particularly with the US FDA. GlobeX's services, based in Switzerland, emphasize data privacy under stringent local laws, providing secure messaging and email solutions for various sectors, including consumers and governments.
- Hemostemix's order of the Sekur platform indicates growing demand for secure communication solutions in the healthcare sector.
- The use of Sekur reinforces GlobeX's position in the cybersecurity market, particularly for regulated industries like stem cell therapy.
- None.
TORONTO, ON and NEW YORK, NY / ACCESSWIRE / March 18, 2021 / GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) ("GlobeX" or the "Company"), the leader in Swiss hosted secure communications and secure data management, is pleased announce that its CEO, Alain Ghiai, joined Steve Darling from Proactive with news to announce that its Swiss hosted secure communications solution, Sekur, has been selected by Stem Cell company Hemostemix inc., a publicly traded company in the TSX Ventures exchange of Canada.
GlobeX Data CEO, Alain Ghiai joined Steve Darling from Proactive to bring news the stem cell company Hemostemix, has placed an order for the Sekur encrypted messaging and secure email platform.
Ghiai tells Proactive Hemostemix, which is in the advanced stages of its research in stem cell therapy, has been looking for an alternate secure and private communications solution to communicate with regulatory authorities, such as the USFDA.
The Interview article and video can be viewed by click this link: GlobeX Data CEO interview
GlobeX's Data privacy solutions are all hosted in Switzerland, protecting users' data from any outside data intrusion requests. In Switzerland, the right to privacy is guaranteed in article 13 of the Swiss Federal Constitution. The Federal Act on Data Protection ("FADP") of 19 June 1992 (in force since 1993) has set up a strict protection of privacy by prohibiting virtually any processing of personal data which is not expressly authorized by the data subjects. The protection is subject to the authority of the Federal Data Protection and Information Commissioner.
Under Swiss federal law, it is a crime to publish information based on leaked "secret official discussions." In 2010 the Federal Supreme Court of Switzerland found that IP addresses are personal information and that under Swiss privacy laws they may not be used to track Internet usage without the knowledge of the individuals involved.
About GlobeX Data Ltd.
GlobeX Data Ltd. is a Cybersecurity and Internet privacy provider of Swiss hosted solutions for secure data management and secure communications. The Company distributes a suite of secure cloud-based storage, disaster recovery, document management, encrypted e-mails, and secure communication tools. GlobeX Data Ltd. sells its products through its approved wholesalers and distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses and governments worldwide.
On behalf of Management
GLOBEX DATA LTD.
Alain Ghiai
President and Chief Executive Officer
+1.416.644.8690
corporate@globexdatagroup.com
For more information please contact GlobeX Data at corporate@globexdatagroup.com or visit us at https://globexdatagroup.com.
For more information on Sekur visit us at: https://www.sekur.com.
Forward Looking Information
This news release contains certain forward-looking information within the meaning of applicable Canadian securities laws ("forward-looking statements"). All statements other than statements of present or historical fact are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as "anticipate", "achieve", "could", "believe", "plan", "intend", "objective", "continuous", "ongoing", "estimate", "outlook", "expect", "project" and similar words, including negatives thereof, suggesting future outcomes or that certain events or conditions "may" or "will" occur. These statements are only predictions. These statements reflect management's current estimates, beliefs, intentions and expectations; they are not guaranteeing future performance. GlobeX cautions that all forward-looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond GlobeX's control. Such factors include, among other things: risks and uncertainties relating to the future of the Company's business; the success of marketing and sales efforts of the Company; the projections prepared in house and projections delivered by channel partners; the Company's ability to complete the necessary software updates; increases in sales as a result of investments software development technology; consumer interest in the Products; future sales plans and strategies; reliance on large channel partners and expectations of renewals to ongoing agreements with these partners; anticipated events and trends; the economy and other future conditions; and other risks and uncertainties, including those described in GlobeX's prospectus dated May 8, 2019 filed with the Canadian Securities Administrators and available on www.sedar.com. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Except as required under applicable securities legislation, GlobeX undertakes no obligation to publicly update or revise forward-looking information.
SOURCE: GlobeX Data Ltd.
View source version on accesswire.com:
https://www.accesswire.com/636240/GlobeX-Data-CEO-Interviewed-on-Proactive-to-Announce-it-Sekurcom-Has-Been-Selected-by-Stem-Cell-Company-Hemostemix
FAQ
What does GlobeX Data Ltd. offer?
Who has selected GlobeX's Sekur platform?
Why did Hemostemix choose Sekur for communications?
How does GlobeX ensure data privacy?
What is the stock symbol for GlobeX Data Ltd.?
